{"id":"https://openalex.org/W2042166364","doi":"https://doi.org/10.1177/0269881112458728","title":"Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial","display_name":"Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial","publication_year":2012,"publication_date":"2012-09-06","ids":{"openalex":"https://openalex.org/W2042166364","doi":"https://doi.org/10.1177/0269881112458728","mag":"2042166364","pmid":"https://pubmed.ncbi.nlm.nih.gov/22954616"},"language":"en","primary_location":{"id":"doi:10.1177/0269881112458728","doi":"https://doi.org/10.1177/0269881112458728","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881112458728","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025495039","display_name":"Kari R. Nations","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kari R Nations","raw_affiliation_strings":["Merck Sharp & Dohme Corp. (formerly Organon), Whitehouse Station, NJ, USA","#N# 1Merck Sharp & Dohme Corp. (formerly Organon), Whitehouse Station, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp. (formerly Organon), Whitehouse Station, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"#N# 1Merck Sharp & Dohme Corp. (formerly Organon), Whitehouse Station, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065632651","display_name":"Peter Dogterom","orcid":"https://orcid.org/0000-0001-8447-2934","observed_orcids":["https://orcid.org/0000-0001-8447-2934"]},"institutions":[{"id":"https://openalex.org/I4210162999","display_name":"MSD (Netherlands)","ror":"https://ror.org/05y28vr04","country_code":"NL","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210162999"]},{"id":"https://openalex.org/I4405279838","display_name":"Organon (Netherlands)","ror":"https://ror.org/02388np20","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405279838"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Peter Dogterom","raw_affiliation_strings":["Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands","2Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands","institution_ids":["https://openalex.org/I4210162999"]},{"raw_affiliation_string":"2Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands","institution_ids":["https://openalex.org/I4405279838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018848503","display_name":"Roberta Bursi","orcid":"https://orcid.org/0000-0001-9118-3786","observed_orcids":["https://orcid.org/0000-0001-9118-3786"]},"institutions":[{"id":"https://openalex.org/I4210162999","display_name":"MSD (Netherlands)","ror":"https://ror.org/05y28vr04","country_code":"NL","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210162999"]},{"id":"https://openalex.org/I4405279838","display_name":"Organon (Netherlands)","ror":"https://ror.org/02388np20","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405279838"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Roberta Bursi","raw_affiliation_strings":["Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands","2Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands","institution_ids":["https://openalex.org/I4210162999"]},{"raw_affiliation_string":"2Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands","institution_ids":["https://openalex.org/I4405279838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023676126","display_name":"Jacques Schipper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162999","display_name":"MSD (Netherlands)","ror":"https://ror.org/05y28vr04","country_code":"NL","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210162999"]},{"id":"https://openalex.org/I4405279838","display_name":"Organon (Netherlands)","ror":"https://ror.org/02388np20","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405279838"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jacques Schipper","raw_affiliation_strings":["Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands","2Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands","institution_ids":["https://openalex.org/I4210162999"]},{"raw_affiliation_string":"2Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands","institution_ids":["https://openalex.org/I4405279838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053129366","display_name":"Scott D. Greenwald","orcid":"https://orcid.org/0000-0001-6067-2907","observed_orcids":["https://orcid.org/0000-0001-6067-2907"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott Greenwald","raw_affiliation_strings":["Covidien (formerly Aspect Medical Systems), Mansfield, MA, USA","#N# 3Covidien (formerly Aspect Medical Systems), Mansfield, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Covidien (formerly Aspect Medical Systems), Mansfield, MA, USA","institution_ids":[]},{"raw_affiliation_string":"#N# 3Covidien (formerly Aspect Medical Systems), Mansfield, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046729505","display_name":"David Zraket","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Zraket","raw_affiliation_strings":["Covidien (formerly Aspect Medical Systems), Mansfield, MA, USA","#N# 3Covidien (formerly Aspect Medical Systems), Mansfield, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Covidien (formerly Aspect Medical Systems), Mansfield, MA, USA","institution_ids":[]},{"raw_affiliation_string":"#N# 3Covidien (formerly Aspect Medical Systems), Mansfield, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077619930","display_name":"Lev Gertsik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124468","display_name":"PAREXEL International (United States)","ror":"https://ror.org/02vkbzw76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124468"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lev Gertsik","raw_affiliation_strings":["California Clinical Trials Medical Group, Inc., PAREXEL International, Glendale, CA, USA","4California Clinical Trials Medical Group, Inc., PAREXEL International, Glendale, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"California Clinical Trials Medical Group, Inc., PAREXEL International, Glendale, CA, USA","institution_ids":["https://openalex.org/I4210124468"]},{"raw_affiliation_string":"4California Clinical Trials Medical Group, Inc., PAREXEL International, Glendale, CA, USA","institution_ids":["https://openalex.org/I4210124468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108522294","display_name":"Jack Johnstone","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jack Johnstone","raw_affiliation_strings":["Q-Metrx, Burbank, CA, USA","#N# 5Q-Metrx, Burbank, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Q-Metrx, Burbank, CA, USA","institution_ids":[]},{"raw_affiliation_string":"#N# 5Q-Metrx, Burbank, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101477146","display_name":"Allen Ting Chun Lee","orcid":"https://orcid.org/0000-0003-4196-5442","observed_orcids":["https://orcid.org/0000-0003-4196-5442"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allen Lee","raw_affiliation_strings":["Merck Sharp & Dohme Corp. (formerly Organon), Whitehouse Station, NJ, USA","#N# 1Merck Sharp & Dohme Corp. (formerly Organon), Whitehouse Station, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp. (formerly Organon), Whitehouse Station, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"#N# 1Merck Sharp & Dohme Corp. (formerly Organon), Whitehouse Station, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054024371","display_name":"Yogesh Pande","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yogesh Pande","raw_affiliation_strings":["Merck Sharp & Dohme Corp. (formerly Organon), Whitehouse Station, NJ, USA","#N# 1Merck Sharp & Dohme Corp. (formerly Organon), Whitehouse Station, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp. (formerly Organon), Whitehouse Station, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"#N# 1Merck Sharp & Dohme Corp. (formerly Organon), Whitehouse Station, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108480623","display_name":"G.S.F. Ruigt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162999","display_name":"MSD (Netherlands)","ror":"https://ror.org/05y28vr04","country_code":"NL","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210162999"]},{"id":"https://openalex.org/I4405279838","display_name":"Organon (Netherlands)","ror":"https://ror.org/02388np20","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405279838"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ge Ruigt","raw_affiliation_strings":["Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands","2Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands","institution_ids":["https://openalex.org/I4210162999"]},{"raw_affiliation_string":"2Merck Sharp & Dohme Oss BV (formerly Organon), Oss, the Netherlands","institution_ids":["https://openalex.org/I4405279838"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009531510","display_name":"Larry Ereshefsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I4210124468","display_name":"PAREXEL International (United States)","ror":"https://ror.org/02vkbzw76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124468"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larry Ereshefsky","raw_affiliation_strings":["California Clinical Trials Medical Group, Inc., PAREXEL International, Glendale, CA, USA","The University of Texas Health Science Center, San Antonio, TX, USA","4California Clinical Trials Medical Group, Inc., PAREXEL International, Glendale, CA, USA","6The University of Texas Health Science Center, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"California Clinical Trials Medical Group, Inc., PAREXEL International, Glendale, CA, USA","institution_ids":["https://openalex.org/I4210124468"]},{"raw_affiliation_string":"The University of Texas Health Science Center, San Antonio, TX, USA","institution_ids":["https://openalex.org/I165951966"]},{"raw_affiliation_string":"4California Clinical Trials Medical Group, Inc., PAREXEL International, Glendale, CA, USA","institution_ids":["https://openalex.org/I4210124468"]},{"raw_affiliation_string":"6The University of Texas Health Science Center, San Antonio, TX, USA","institution_ids":["https://openalex.org/I165951966"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":4.9567,"has_fulltext":false,"cited_by_count":75,"citation_normalized_percentile":{"value":0.95366346,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"26","issue":"12","first_page":"1525","last_page":"1539"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9929999709129333},{"id":"https://openalex.org/keywords/glutamatergic-neurotransmission","display_name":"glutamatergic neurotransmission","score":0.8790000081062317},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8349999785423279},{"id":"https://openalex.org/keywords/dose-titration","display_name":"dose titration","score":0.8330000042915344},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7889999747276306},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9940000176429749},{"id":"https://openalex.org/keywords/executive-function","display_name":"executive function","score":0.6200000047683716},{"id":"https://openalex.org/keywords/processing-speed","display_name":"processing speed","score":0.7139999866485596},{"id":"https://openalex.org/keywords/growth-hormone","display_name":"growth hormone","score":0.968999981880188},{"id":"https://openalex.org/keywords/cortisol","display_name":"cortisol","score":0.996999979019165},{"id":"https://openalex.org/keywords/brain-derived-neurotrophic-factor","display_name":"brain-derived neurotrophic factor","score":0.9200000166893005},{"id":"https://openalex.org/keywords/quantitative-eeg","display_name":"quantitative EEG","score":0.753000020980835},{"id":"https://openalex.org/keywords/antidepressant-response","display_name":"antidepressant response","score":0.7400000095367432},{"id":"https://openalex.org/keywords/antidepressant-response-prediction","display_name":"antidepressant response prediction","score":0.5989999771118164}],"concepts":[{"id":"https://openalex.org/C160268369","wikidata":"https://www.wikidata.org/wiki/Q295251","display_name":"AMPA receptor","level":4,"score":0.7275363206863403},{"id":"https://openalex.org/C2776038425","wikidata":"https://www.wikidata.org/wiki/Q2649417","display_name":"Allosteric modulator","level":4,"score":0.6872346997261047},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6453759670257568},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.5334396958351135},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5035843253135681},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.49178174138069153},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.4853062033653259},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4582591950893402},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.41314345598220825},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40694689750671387},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4015730023384094},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35168153047561646},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.34248584508895874},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.33420270681381226},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.29659318923950195},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.2016054391860962},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.11189380288124084},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08989310264587402},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006854","descriptor_name":"Hydrocortisone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018091","descriptor_name":"Receptors, AMPA","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018350","descriptor_name":"alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018350","descriptor_name":"alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018350","descriptor_name":"alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D018350","descriptor_name":"alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019382","descriptor_name":"Human Growth Hormone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/0269881112458728","doi":"https://doi.org/10.1177/0269881112458728","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881112458728","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:22954616","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22954616","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":68,"referenced_works":["https://openalex.org/W1780394705","https://openalex.org/W1964537139","https://openalex.org/W1970133878","https://openalex.org/W1971557845","https://openalex.org/W1971614777","https://openalex.org/W1980049394","https://openalex.org/W1982058167","https://openalex.org/W1988303426","https://openalex.org/W1991330295","https://openalex.org/W1997808826","https://openalex.org/W1998441150","https://openalex.org/W1999871144","https://openalex.org/W2001638562","https://openalex.org/W2004807126","https://openalex.org/W2008565079","https://openalex.org/W2009412535","https://openalex.org/W2015118408","https://openalex.org/W2020118281","https://openalex.org/W2021069714","https://openalex.org/W2022279290","https://openalex.org/W2023081218","https://openalex.org/W2025005051","https://openalex.org/W2030254267","https://openalex.org/W2032739515","https://openalex.org/W2037227674","https://openalex.org/W2043052878","https://openalex.org/W2043283741","https://openalex.org/W2043576181","https://openalex.org/W2048398100","https://openalex.org/W2049492562","https://openalex.org/W2050493044","https://openalex.org/W2054143740","https://openalex.org/W2054931962","https://openalex.org/W2058128885","https://openalex.org/W2061088962","https://openalex.org/W2061731402","https://openalex.org/W2062190490","https://openalex.org/W2065521724","https://openalex.org/W2067529879","https://openalex.org/W2069644503","https://openalex.org/W2071430187","https://openalex.org/W2071949058","https://openalex.org/W2074772639","https://openalex.org/W2077532061","https://openalex.org/W2090514581","https://openalex.org/W2097152162","https://openalex.org/W2098750661","https://openalex.org/W2099531461","https://openalex.org/W2103995565","https://openalex.org/W2107984515","https://openalex.org/W2109105506","https://openalex.org/W2109334244","https://openalex.org/W2117766577","https://openalex.org/W2119397822","https://openalex.org/W2119694325","https://openalex.org/W2131053945","https://openalex.org/W2131823335","https://openalex.org/W2132324173","https://openalex.org/W2144237113","https://openalex.org/W2144269887","https://openalex.org/W2162541816","https://openalex.org/W2166435242","https://openalex.org/W2167212605","https://openalex.org/W2189057525","https://openalex.org/W3090293687","https://openalex.org/W3171418018","https://openalex.org/W4243757772","https://openalex.org/W4300870773"],"related_works":["https://openalex.org/W2095159395","https://openalex.org/W4313201328","https://openalex.org/W7208828768","https://openalex.org/W3083989994","https://openalex.org/W1963831800","https://openalex.org/W1989017915","https://openalex.org/W2405100977","https://openalex.org/W4280521929","https://openalex.org/W2240673715","https://openalex.org/W2141979672"],"abstract_inverted_index":{"Org":[0,30,128,161,219],"26576":[1,31,129,162,220],"acts":[2],"by":[3,117],"modulating":[4],"ionotropic":[5],"AMPA-type":[6],"glutamate":[7],"receptors":[8],"to":[9,22,58,77,199],"enhance":[10],"glutamatergic":[11],"neurotransmission.":[12],"The":[13,187],"aim":[14],"of":[15,29,90,157,176,245],"this":[16],"Phase":[17],"1b":[18],"study":[19,138],"(N=54)":[20],"was":[21,109,123,148,163,197,212],"explore":[23],"safety,":[24],"tolerability,":[25],"pharmacokinetics,":[26],"and":[27,44,155,170,224,230],"pharmacodynamics":[28],"in":[32,48,106,126,132,136,152,206,215,227,239],"depressed":[33,228],"patients.":[34],"Part":[35,62,107,141],"I":[36,108],"(N=24)":[37],"evaluated":[38],"the":[39,88,97,103,118,127,133,143,174,207],"maximum":[40],"tolerated":[41],"dose":[42,52,101,147],"(MTD)":[43],"optimal":[45],"titration":[46],"schedule":[47],"a":[49,66,82],"multiple":[50],"rising":[51],"paradigm":[53],"(range":[54],"100":[55],"mg":[56,60,71,74,99,111,145],"BID":[57,100,146],"600":[59,98],"BID);":[61],"II":[63],"(N=30)":[64],"utilized":[65],"parallel":[67],"groups":[68,130],"design":[69],"(100":[70],"BID,":[72,75],"400":[73,144],"placebo)":[76],"examine":[78],"all":[79],"endpoints":[80,232],"over":[81],"28-day":[83],"dosing":[84],"period.":[85],"Based":[86],"on":[87],"number":[89],"moderate":[91],"intensity":[92],"adverse":[93],"events":[94],"reported":[95],"at":[96,173,194,204],"level,":[102],"MTD":[104],"established":[105],"450":[110],"BID.":[112],"Symptomatic":[113],"improvement":[114,214],"as":[115,211],"measured":[116],"Montgomery-Asberg":[119],"Depression":[120],"Rating":[121],"Scale":[122],"numerically":[124],"greater":[125],"than":[131],"placebo":[134],"group":[135],"both":[137],"parts.":[139],"In":[140],"II,":[142],"associated":[149,165],"with":[150,166],"improvements":[151],"executive":[153],"functioning":[154],"speed":[156],"processing":[158],"cognitive":[159],"tests.":[160],"also":[164],"growth":[167],"hormone":[168],"increases":[169],"cortisol":[171],"decreases":[172],"end":[175],"treatment":[177,209],"but":[178],"did":[179],"not":[180],"influence":[181],"prolactin":[182],"or":[183],"brain-derived":[184],"neurotrophic":[185],"factor.":[186],"quantitative":[188],"electroencephalogram":[189],"index":[190],"Antidepressant":[191],"Treatment":[192],"Response":[193],"Week":[195],"1":[196],"able":[198],"significantly":[200],"predict":[201],"symptomatic":[202],"response":[203],"endpoint":[205],"active":[208],"group,":[210],"early":[213],"social":[216],"acuity.":[217],"Overall,":[218],"demonstrated":[221],"good":[222],"tolerability":[223],"pharmacokinetic":[225],"properties":[226],"patients,":[229],"pharmacodynamic":[231],"suggested":[233],"that":[234],"it":[235],"may":[236],"show":[237],"promise":[238],"future":[240],"well-controlled,":[241],"adequately":[242],"powered":[243],"proof":[244],"concept":[246],"trials.":[247]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}